Changes in the Management of Patients with Crohn’s Disease Based on Magnetic Resonance Enterography Patterns
Table 3
Agreement of magnetic resonance enterography parameters with selected clinical, endoscopic, and laboratory variables.
Patient variable
MRE patterns
Inflammatory
Penetrating
Fibrostenosing
Absent ()
Present ()
value
Absent ()
Present ()
value
Absent ()
Present ()
value
()
21 (77.8%)
25 (53.2%)
0.037
34 (65.4%)
12 (54.5%)
0.383
28 (65.1%)
18 (58.1%)
0.540
()
6 (22.2%)
22 (46.8%)
18 (34.6%)
10 (45.5%)
15 (34.9%)
13 (41.9%)
Disease duration (years)
7 (3-12)
9 (5-20)
0.278
7 (4-12)
10 (5.8-25.8)
0.107
6 (4-11)
12 (6-20)
0.027
CRP (mg/L)
2.1 (1.0-6.1)
3 (1.9-5.7)
0.202
2.9 (1.4-5.2)
2.6 (1.3-13.4)
0.789
2.3 (1.2-7.8)
3.6 (2.1-6.1)
0.335
ESR (mm/h)
19 (10-35)
30 (19-45)
0.128
29 (16-42)
24 (12-35)
0.466
21 (16-38)
30 (17-42)
0.514
Haemoglobin (g/dL)
13.4 (12.7-13.7)
12.3 (11.4-13.9)
0.215
12.9 (11.5-13.6)
13.6 (11.4-14.1)
0.150
13.1 (11.6-13.7)
13 (11.5-14)
0.924
Calprotectin (μg/g)
76 (28-171)
255 (107-618)
0.005
183 (107-490)
89 (79-932)
0.885
142 (43-201)
288 (88-965)
0.105
SES-CD
4 (1-9.3)
4 (1.5-11.5)
0.474
3 (0.5-8.5)
8 (2.8-13)
0.048
4.5 (1.8-10)
4 (1-10.5)
0.876
Rutgeerts
0 (0-2.5)
2 (0-3)
0.336
1 (0-3)
2.5 (1.3-3)
0.177
1 (0-3)
2 (0-3)
0.671
MRE: magnetic resonance enterography. The MRE patterns analysed are not mutually exclusive. Values are presented as numbers, with percentages in parentheses, or as the median with the interquartile range; HBI: Harvey and Bradshaw index; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; SES-CD: scoring endoscopic system for Crohn’s disease; Rutgeerts: scoring endoscopic system for postoperative patients with Crohn’s disease.